Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 GBX | -2.13% | +3.37% | +16.75% |
Apr. 05 | RUA Life Sciences expects flat annual revenue on strong second half | AN |
Apr. 05 | RUA Life Sciences plc Provides Revenue Guidance for the Year Ended 31 March 2024 | CI |
Sales 2024 * | 2.24M 2.81M | Sales 2025 * | 3.28M 4.11M | Capitalization | 7.14M 8.94M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.25M | Net income 2025 * | - 0 | EV / Sales 2024 * | 1.55 x |
Net cash position 2024 * | 3.66M 4.58M | Net cash position 2025 * | 2.95M 3.69M | EV / Sales 2025 * | 1.28 x |
P/E ratio 2024 * |
-2.65
x | P/E ratio 2025 * |
-7.67
x | Employees | 48 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.93% |
Latest transcript on RUA Life Sciences plc
1 day | -2.13% | ||
1 week | +3.37% | ||
1 month | -6.12% | ||
3 months | +6.98% | ||
6 months | -11.54% | ||
Current year | +16.75% |
Managers | Title | Age | Since |
---|---|---|---|
Lachlan Smith
DFI | Director of Finance/CFO | - | 21-11-30 |
Bill Brown
CHM | Chairman | 55 | 11-10-20 |
John McKenna
BRD | Director/Board Member | 71 | 16-10-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Brown
CHM | Chairman | 55 | 11-10-20 |
John Louis Ely
BRD | Director/Board Member | 73 | - |
Director/Board Member | 57 | 21-01-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 11.5 | -2.13% | 201,352 |
24-05-09 | 11.75 | 0.00% | 314,535 |
24-05-08 | 11.75 | +2.17% | 200,480 |
24-05-07 | 11.5 | +1.10% | 254,532 |
24-05-03 | 11.38 | +2.25% | 90,931 |
Delayed Quote London S.E., May 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.75% | 9.13M | |
+11.73% | 221B | |
+9.53% | 186B | |
+14.63% | 137B | |
+27.47% | 109B | |
-0.04% | 63.09B | |
+13.73% | 52.68B | |
+4.86% | 50.86B | |
+7.72% | 42.53B | |
+7.86% | 37.76B |
- Stock Market
- Equities
- AOR Stock